Sharon Townson insider trades

Open-market stock purchases and sales by Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics, Inc, from SEC Form 4 filings since Mar 1, 2022.

Recent trades

DateStockTradeValue
Jun 23, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Jun 23, 2026GLUE Monte Rosa Therapeutics, IncSold$60K
Jun 17, 2026GLUE Monte Rosa Therapeutics, IncSold$57K
Jun 17, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
May 29, 2026GLUE Monte Rosa Therapeutics, IncSold$119K
May 29, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Jan 5, 2026GLUE Monte Rosa Therapeutics, IncSold$47.9K
Jan 2, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Jan 2, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—

Companies traded

  • GLUE Monte Rosa Therapeutics, Inc: 4 sales, last Jun 23, 2026

Get free alerts when Sharon Townson files a new trade →